Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-Life Evaluation of Guselkumab Dosing Interval Adjustments. SPAcing-GUS

NCT07430319 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT07430319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07430319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-Life Evaluation of Guselkumab Dosing Interval Adjustments. SPAcing-GUS
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Observational
Overall status
Recruiting
Start date
October 16, 2025
Completion date
April 16, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis